{"id":"W3206372141","doi":"10.1016/j.ejca.2021.09.016","title":"Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era","year":2021,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb Canada; Astellas Pharma Canada; International Studies Association; Novartis; Celgene; Bayer; AstraZeneca; Amgen; Pfizer; Meso Scale Diagnostics; AbbVie; Merck","keywords":"Maximum tolerated dose; Medicine; Clinical trial; Therapeutic window; Intensive care medicine; Medical physics; Computer science; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00718415,0.0002842658,0.001764574,0.0002922184,0.00005872762,0.00006400338,0.0003600279,0.00006052149,0.0002246764],"category_scores_gemma":[0.0003179109,0.0001621359,0.000854414,0.0004303982,0.0001245351,0.00008181493,0.00004379412,0.001176615,0.000003700941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002785692,"about_ca_system_score_gemma":0.001008554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003863489,"about_ca_topic_score_gemma":8.378171e-7,"domain_scores_codex":[0.9940686,0.003814421,0.001246394,0.0001949111,0.0004478992,0.0002278152],"domain_scores_gemma":[0.9968919,0.001159076,0.0008546776,0.0003567331,0.0006649113,0.00007267442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003421009,0.000128966,0.000004916047,0.002546943,0.001622635,0.0003522072,0.001578252,5.488916e-7,0.0001081411,0.000005836184,0.002969078,0.9903404],"study_design_scores_gemma":[0.003509443,0.0009395927,0.00003109108,0.01537316,0.0008476641,0.0002521904,0.0002803322,0.000002566564,0.00001654284,0.000007886241,0.9786022,0.000137376],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003750329,0.9947623,0.0009935809,0.0005384839,0.0006593621,0.001004298,0.00001377482,0.000005388504,0.001985313],"genre_scores_gemma":[0.00003764611,0.9923233,0.003122909,0.0003502581,0.00146479,0.00003414874,0.00001071524,0.0001113984,0.002544773],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.990203,"threshold_uncertainty_score":0.6611709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4579977353478128,"score_gpt":0.597604700362081,"score_spread":0.1396069650142682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}